Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending October 12, 2012. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on capital structure and share buyback activity.
- Shares Purchased: 800,000 Ordinary Shares of 25 pence each.
- Purchase Date: October 12, 2012.
- Price Range: Highest price paid was 1,430.5 pence per share; lowest price paid was 1,412.5 pence per share.
- Treasury Holdings (Settled): 505,330,427 shares (9.28% of total issued share capital).
- Treasury Holdings (Including Unsettled): 507,110,427 shares (10.27% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,939,751,188 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 800,000 shares for Treasury. Consequently, the percentage of total voting rights held in Treasury increased to 10.27% when including unsettled shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance disclosure confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (505,330,427 settled) against the company's latest capitalization table.
- Confirm the calculation of voting rights (10.27% held in Treasury including unsettled shares) for disclosure threshold assessments.
- Check the total issued share capital excluding Treasury shares (4,939,751,188) for EPS denominator calculations.
- Review the price range paid (1,412.5 to 1,430.5 pence) to assess the cost of capital relative to market prices on October 12, 2012.